No Data
No Data
Chenguang Biotech Group (300138.SZ): Has cumulatively repurchased 7.05% of its shares.
Chenguang Biotech Group (300138.SZ) announced on July 5th that as of July 4th, 2024, the company repurchased 37,548,998 shares of its own stock through a buyback special securities account using centralized bidding trading method, with a transaction amount of RMB 400,804,580.36 (excluding transaction costs). The proportion of shares repurchased this time accounted for 7.05% of the company's total share capital. The highest fill price for the buyback shares was 14 yuan/share, and the lowest fill price was 8.13 yuan/share.
Chenguang Biotech Group (300138.SZ): The ginkgo leaf business is still in the expansion phase, with revenue accounting for less than 1% of the total revenue.
Chenguang Biotech Group (300138.SZ) stated on the investor platform that the company's traditional chinese medicine ginkgo leaf products mainly include silver ginkgo leaf blades, health supplements of ginkgo leaf red yeast capsules, and medicinal ginkgo leaf extracts. This category of products is in the business expansion period, and related business revenue accounts for less than 1% of the company's overall revenue.
Chenguang Biotech Group (300138.SZ): has accumulated repurchased 6.96% of its shares.
Chenguang Biotech Group (300138.SZ) announced that as of June 30, 2024, the company repurchased 37,103,398 shares through a repurchase dedicated securities account in a centralized bidding trading manner, with a deal amount of CNY 397,065,025.36 (excluding transaction costs). This repurchase accounts for 6.96% of the company's total share capital. The highest fill price of this repurchased shares was 14 yuan/share and the lowest fill price was 8.13 yuan/share.
Chenguang Biotech Group (300138.SZ): QG is a company animal health product made from chrysanthemum flavonoids that is currently being produced and sold.
On June 6th, Gelunhui reported that an investor asked Chenguang Biotech Group (300138.SZ) on the investor interaction platform, "Has the production of Quercetin Glycosides (QG) as a new feed additive started, or how is it planned for the future?" The company replied that Quercetin Glycosides (QG) is an animal feed product of the company, which has already been produced and sold. Its revenue accounts for less than 0.1% of the company's overall revenue.
Chenguang Biotech Group (300138.SZ): 10 dividends of 1.3 yuan per share will be distributed for the year 2023, and the equity registration date is June 12th.
Chenguang Biotech Group (300138.SZ) announced that the annual equity distribution plan for 2023 is as follows: based on the total shares of the company's existing stock after deducting 33,413,298 repurchased shares, which is 499,360,693 shares, a cash dividend of RMB 1.300000 per 10 shares will be distributed to all shareholders (including tax). The equity distribution record date for this distribution is June 12, 2024, and the ex-rights and ex-dividend date is June 13, 2024.
Chenguang Biotech Group (300138.SZ) has spent a total of 346 million yuan to repurchase 5.84% of its shares.
Chenguang Biotech Group (300138.SZ) announced that as of May 31, 2024, the company repurchased a total of 31,107,298 shares of the company through the repurchase special securities account in a centralized auction trading manner, with a transaction amount of RMB 346,121,654.45 (excluding transaction fees). The proportion of the repurchased shares to the company's total share capital was 5.84%. The highest transaction price of the repurchased shares in this repurchase was 14 yuan/share, and the lowest transaction price was 8.92 yuan/share. This buyback complies with the company's share repurchase plan and relevant laws and regulations.
No Data